Share Price and Basic Stock Data
Last Updated: December 12, 2025, 7:48 pm
| PEG Ratio | 1.49 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deccan Health Care Ltd operates in the Hospitals and Medical Services sector, a critical industry that has witnessed significant growth in recent years. The company reported a revenue of ₹45.02 Cr for the fiscal year ending March 2023, marking a substantial increase from ₹33.17 Cr in the previous year. This upward trajectory continued into the trailing twelve months (TTM), where revenues surged to ₹81.54 Cr. Notably, the quarterly sales data indicates a consistent improvement, with revenues climbing from ₹11.77 Cr in September 2022 to ₹17.19 Cr in September 2023. This growth is indicative of the company’s ability to capitalize on the expanding healthcare needs in India, especially in a post-pandemic environment. However, fluctuations in quarterly sales, particularly the dip to ₹8.65 Cr in December 2022, suggest that while the overall trend is positive, seasonal factors may still impact performance.
Profitability and Efficiency Metrics
Despite the encouraging revenue growth, Deccan Health Care Ltd’s profitability metrics present a mixed picture. The operating profit margin (OPM) stood at a modest 4.23% for the fiscal year 2025, significantly lower than the sector average, which typically hovers around 15% for established players. The net profit margin was recorded at 1.54%, reflecting the company’s struggle to maintain profitability amidst rising costs. Moreover, the return on equity (ROE) and return on capital employed (ROCE) are relatively low, at 1.18% and 1.69%, respectively. This suggests that while the company is generating revenue, it is not translating this into substantial profits, potentially due to high operational expenses. The interest coverage ratio (ICR) of 42.55x indicates that the company is comfortably managing its interest obligations, a positive sign in terms of financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Deccan Health Care Ltd appears robust, with total assets reported at ₹123.93 Cr against total liabilities of ₹107.32 Cr, reflecting a healthy asset-to-liability ratio. Reserves have steadily increased to ₹84.21 Cr, indicating a solid foundation for future growth. The company’s low borrowings of ₹1.33 Cr demonstrate prudent financial management, with a long-term debt-to-equity ratio of just 0.01, suggesting that the company is not heavily reliant on debt for its operations. However, the price-to-book value ratio of 0.37x raises questions about market sentiment and valuation, indicating that the stock may be undervalued compared to its book value. Furthermore, the cash conversion cycle (CCC) of 319.07 days suggests inefficiencies in managing working capital, which could impact liquidity in the long run.
Shareholding Pattern and Investor Confidence
Deccan Health Care Ltd’s shareholding pattern reveals a diverse ownership structure. As of September 2025, promoters held 18.42% of the shares, while domestic institutional investors (DIIs) accounted for 5.37%. Public ownership is substantial at 76.21%, indicating a broad base of retail investors. The increasing number of shareholders, which rose from 897 in March 2023 to 3,743 by September 2025, reflects growing investor interest and confidence in the company’s prospects. However, the declining promoter shareholding from 22.21% in March 2023 to 18.42% raises some concerns about insider confidence. This trend could indicate a potential dilution of control, which may worry investors about the long-term strategic direction of the company.
Outlook, Risks, and Final Insight
Looking ahead, Deccan Health Care Ltd presents a mixed bag of opportunities and risks. The consistent revenue growth suggests that the company is well-positioned to benefit from the expanding healthcare market in India. However, challenges such as low profitability margins and high cash conversion cycles could hinder its ability to capitalize on this growth fully. Investors should remain cautious about the implications of the declining promoter shareholding and the company’s operational inefficiencies. While the robust balance sheet and low debt levels are strengths, the market’s perception, reflected in the low price-to-book ratio, indicates that the stock may not yet be fully recognized by investors. Overall, while Deccan Health Care Ltd has the potential for growth, it is essential for investors to weigh the risks carefully and monitor the company’s operational strategies and market conditions closely.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 43.2 Cr. | 129 | 195/120 | 8.83 | 117 | 2.71 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 22.0 Cr. | 21.0 | 35.5/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 9.00 Cr. | 8.70 | 20.8/8.66 | 100 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 115 Cr. | 61.3 | 98.7/55.2 | 25.4 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 20.1 Cr. | 3.72 | 7.29/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 26,323.57 Cr | 758.87 | 94.10 | 99.39 | 0.32% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.74 | 11.77 | 8.65 | 15.86 | 11.22 | 17.19 | 15.34 | 15.97 | 15.06 | 18.82 | 20.43 | 20.82 | 21.47 |
| Expenses | 8.10 | 10.96 | 8.83 | 15.07 | 10.40 | 16.16 | 14.10 | 15.31 | 14.19 | 17.70 | 19.83 | 20.19 | 20.75 |
| Operating Profit | 0.64 | 0.81 | -0.18 | 0.79 | 0.82 | 1.03 | 1.24 | 0.66 | 0.87 | 1.12 | 0.60 | 0.63 | 0.72 |
| OPM % | 7.32% | 6.88% | -2.08% | 4.98% | 7.31% | 5.99% | 8.08% | 4.13% | 5.78% | 5.95% | 2.94% | 3.03% | 3.35% |
| Other Income | -0.00 | -0.00 | 0.01 | 0.01 | 0.01 | -0.00 | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | 0.01 |
| Interest | 0.02 | 0.03 | 0.04 | 0.03 | 0.02 | -0.00 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| Depreciation | 0.36 | 0.36 | 0.36 | 0.36 | 0.39 | 0.32 | 0.40 | 0.36 | 0.36 | 0.37 | 0.37 | 0.36 | 0.41 |
| Profit before tax | 0.26 | 0.42 | -0.57 | 0.41 | 0.42 | 0.71 | 0.82 | 0.29 | 0.49 | 0.72 | 0.21 | 0.25 | 0.30 |
| Tax % | 26.92% | 23.81% | -24.56% | 26.83% | 26.19% | 25.35% | 32.93% | 58.62% | 26.53% | 25.00% | 23.81% | 44.00% | 30.00% |
| Net Profit | 0.20 | 0.32 | -0.43 | 0.31 | 0.31 | 0.53 | 0.55 | 0.13 | 0.37 | 0.54 | 0.16 | 0.14 | 0.21 |
| EPS in Rs | 0.12 | 0.19 | -0.25 | 0.18 | 0.18 | 0.31 | 0.27 | 0.06 | 0.18 | 0.26 | 0.07 | 0.06 | 0.09 |
Last Updated: August 19, 2025, 8:20 pm
Below is a detailed analysis of the quarterly data for Deccan Health Care Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 21.47 Cr.. The value appears strong and on an upward trend. It has increased from 20.82 Cr. (Mar 2025) to 21.47 Cr., marking an increase of 0.65 Cr..
- For Expenses, as of Jun 2025, the value is 20.75 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.19 Cr. (Mar 2025) to 20.75 Cr., marking an increase of 0.56 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.72 Cr.. The value appears strong and on an upward trend. It has increased from 0.63 Cr. (Mar 2025) to 0.72 Cr., marking an increase of 0.09 Cr..
- For OPM %, as of Jun 2025, the value is 3.35%. The value appears strong and on an upward trend. It has increased from 3.03% (Mar 2025) to 3.35%, marking an increase of 0.32%.
- For Other Income, as of Jun 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.36 Cr. (Mar 2025) to 0.41 Cr., marking an increase of 0.05 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.30 Cr.. The value appears strong and on an upward trend. It has increased from 0.25 Cr. (Mar 2025) to 0.30 Cr., marking an increase of 0.05 Cr..
- For Tax %, as of Jun 2025, the value is 30.00%. The value appears to be improving (decreasing) as expected. It has decreased from 44.00% (Mar 2025) to 30.00%, marking a decrease of 14.00%.
- For Net Profit, as of Jun 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.14 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.07 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.09. The value appears strong and on an upward trend. It has increased from 0.06 (Mar 2025) to 0.09, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:32 am
| Metric | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.26 | 39.52 | 16.16 | 29.34 | 37.83 | 44.25 | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.13 | 81.54 |
| Expenses | 28.28 | 38.54 | 9.81 | 16.54 | 23.77 | 27.44 | 30.57 | 31.74 | 27.54 | 42.97 | 55.97 | 71.95 | 78.47 |
| Operating Profit | 0.98 | 0.98 | 6.35 | 12.80 | 14.06 | 16.81 | 11.67 | 2.04 | 5.63 | 2.05 | 3.76 | 3.18 | 3.07 |
| OPM % | 3.35% | 2.48% | 39.29% | 43.63% | 37.17% | 37.99% | 27.63% | 6.04% | 16.97% | 4.55% | 6.29% | 4.23% | 3.77% |
| Other Income | 0.09 | 0.09 | -0.17 | 0.05 | 2.07 | 0.08 | 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 |
| Interest | 0.01 | 0.10 | 1.48 | 2.14 | 1.50 | 1.04 | 0.18 | 0.11 | 0.15 | 0.11 | 0.06 | 0.07 | 0.09 |
| Depreciation | 0.02 | 0.22 | 1.15 | 1.19 | 1.28 | 1.29 | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.51 |
| Profit before tax | 1.04 | 0.75 | 3.55 | 9.52 | 13.35 | 14.56 | 10.13 | 0.52 | 0.55 | 0.53 | 2.24 | 1.67 | 1.48 |
| Tax % | 17.31% | 30.67% | 0.28% | -0.21% | -0.15% | 0.62% | 0.39% | 25.00% | 40.00% | 26.42% | 32.59% | 28.14% | |
| Net Profit | 0.86 | 0.53 | 3.54 | 9.54 | 13.36 | 14.48 | 10.09 | 0.39 | 0.32 | 0.40 | 1.52 | 1.20 | 1.05 |
| EPS in Rs | 1.61 | 0.99 | 3.39 | 7.38 | 9.90 | 9.22 | 6.42 | 0.25 | 0.20 | 0.23 | 0.75 | 0.51 | 0.48 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2009-2010 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -38.37% | 169.49% | 40.04% | 8.38% | -30.32% | -96.13% | -17.95% | 25.00% | 280.00% | -21.05% |
| Change in YoY Net Profit Growth (%) | 0.00% | 207.86% | -129.45% | -31.66% | -38.70% | -65.82% | 78.19% | 42.95% | 255.00% | -301.05% |
Deccan Health Care Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2009-2010 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 31% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -35% |
| 3 Years: | -20% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -14% |
| 3 Years: | -15% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 3:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:43 am
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.33 | 5.33 | 10.43 | 12.93 | 13.50 | 15.71 | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 1.24 | 11.08 | -2.03 | 9.21 | 32.68 | 50.43 | 60.52 | 60.91 | 61.23 | 64.61 | 76.66 | 83.13 | 84.21 |
| Borrowings | 0.00 | 10.46 | 13.94 | 10.94 | 10.90 | 1.41 | 1.30 | 1.03 | 1.25 | 1.55 | 1.41 | 1.15 | 1.33 |
| Other Liabilities | 3.02 | 3.29 | 7.00 | 16.51 | 13.40 | 15.30 | 15.46 | 14.61 | 12.44 | 13.28 | 8.87 | 16.22 | 25.90 |
| Total Liabilities | 9.59 | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 136.19 |
| Fixed Assets | 0.08 | 18.54 | 17.12 | 17.32 | 17.71 | 20.85 | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 13.69 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.51 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 9.51 | 11.62 | 12.22 | 32.25 | 49.26 | 62.00 | 71.74 | 72.31 | 72.09 | 79.62 | 91.62 | 109.54 | 122.49 |
| Total Assets | 9.59 | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 136.19 |
Below is a detailed analysis of the balance sheet data for Deccan Health Care Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 24.75 Cr.. The value appears strong and on an upward trend. It has increased from 23.43 Cr. (Mar 2025) to 24.75 Cr., marking an increase of 1.32 Cr..
- For Reserves, as of Sep 2025, the value is 84.21 Cr.. The value appears strong and on an upward trend. It has increased from 83.13 Cr. (Mar 2025) to 84.21 Cr., marking an increase of 1.08 Cr..
- For Borrowings, as of Sep 2025, the value is 1.33 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.15 Cr. (Mar 2025) to 1.33 Cr., marking an increase of 0.18 Cr..
- For Other Liabilities, as of Sep 2025, the value is 25.90 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.22 Cr. (Mar 2025) to 25.90 Cr., marking an increase of 9.68 Cr..
- For Total Liabilities, as of Sep 2025, the value is 136.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 123.93 Cr. (Mar 2025) to 136.19 Cr., marking an increase of 12.26 Cr..
- For Fixed Assets, as of Sep 2025, the value is 13.69 Cr.. The value appears to be declining and may need further review. It has decreased from 14.38 Cr. (Mar 2025) to 13.69 Cr., marking a decrease of 0.69 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Other Assets, as of Sep 2025, the value is 122.49 Cr.. The value appears strong and on an upward trend. It has increased from 109.54 Cr. (Mar 2025) to 122.49 Cr., marking an increase of 12.95 Cr..
- For Total Assets, as of Sep 2025, the value is 136.19 Cr.. The value appears strong and on an upward trend. It has increased from 123.93 Cr. (Mar 2025) to 136.19 Cr., marking an increase of 12.26 Cr..
Notably, the Reserves (84.21 Cr.) exceed the Borrowings (1.33 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.98 | -9.48 | -7.59 | 1.86 | 3.16 | 15.40 | 10.37 | 1.01 | 4.38 | 0.50 | 2.35 | 2.03 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52.39 | 50.24 | 181.82 | 229.90 | 170.49 | 159.86 | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 61.26 |
| Inventory Days | 48.33 | 34.08 | 269.62 | 432.36 | 596.97 | 773.64 | 825.88 | 890.81 | 1,182.75 | 683.64 | 445.05 | 326.33 |
| Days Payable | 42.96 | 31.06 | 264.36 | 447.94 | 173.22 | 185.88 | 153.84 | 112.09 | 146.00 | 123.28 | 41.39 | 68.52 |
| Cash Conversion Cycle | 57.76 | 53.25 | 187.08 | 214.32 | 594.24 | 747.62 | 849.70 | 913.46 | 1,177.82 | 657.58 | 464.10 | 319.07 |
| Working Capital Days | 55.51 | 51.72 | -155.17 | 193.82 | 240.82 | 321.94 | 421.77 | 545.99 | 603.01 | 502.26 | 477.19 | 423.69 |
| ROCE % | 5.08% | 42.08% | 32.94% | 25.03% | 14.21% | 0.81% | 5.62% | 0.79% | 2.53% | 1.69% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.54 | 0.80 | 0.22 | 0.21 | 0.25 |
| Diluted EPS (Rs.) | 0.45 | 0.80 | 0.22 | 0.21 | 0.25 |
| Cash EPS (Rs.) | 1.11 | 1.45 | 1.05 | 1.14 | 1.18 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 45.42 | 47.56 | 47.86 | 48.97 | 48.76 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 45.42 | 47.56 | 47.86 | 48.97 | 48.76 |
| Revenue From Operations / Share (Rs.) | 32.04 | 29.31 | 26.42 | 21.11 | 21.49 |
| PBDIT / Share (Rs.) | 1.35 | 1.85 | 1.21 | 3.54 | 1.33 |
| PBIT / Share (Rs.) | 0.72 | 1.13 | 0.36 | 2.61 | 0.39 |
| PBT / Share (Rs.) | 0.69 | 1.09 | 0.30 | 0.34 | 0.33 |
| Net Profit / Share (Rs.) | 0.49 | 0.73 | 0.21 | 0.20 | 0.24 |
| NP After MI And SOA / Share (Rs.) | 0.49 | 0.73 | 0.21 | 0.20 | 0.24 |
| PBDIT Margin (%) | 4.20 | 6.30 | 4.56 | 16.78 | 6.19 |
| PBIT Margin (%) | 2.27 | 3.84 | 1.39 | 12.34 | 1.85 |
| PBT Margin (%) | 2.17 | 3.70 | 1.14 | 1.63 | 1.53 |
| Net Profit Margin (%) | 1.54 | 2.49 | 0.80 | 0.97 | 1.15 |
| NP After MI And SOA Margin (%) | 1.54 | 2.49 | 0.80 | 0.97 | 1.15 |
| Return on Networth / Equity (%) | 1.08 | 1.54 | 0.44 | 0.41 | 0.50 |
| Return on Capital Employeed (%) | 1.56 | 2.28 | 0.73 | 5.10 | 0.78 |
| Return On Assets (%) | 0.92 | 1.38 | 0.37 | 0.35 | 0.42 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.64 | 0.58 | 0.48 | 0.36 | 0.00 |
| Current Ratio (X) | 6.77 | 11.76 | 6.33 | 6.48 | 5.23 |
| Quick Ratio (X) | 4.05 | 5.67 | 2.43 | 2.05 | 1.69 |
| Inventory Turnover Ratio (X) | 1.70 | 0.65 | 0.68 | 0.08 | 0.00 |
| Interest Coverage Ratio (X) | 42.55 | 44.30 | 18.74 | 36.67 | 19.40 |
| Interest Coverage Ratio (Post Tax) (X) | 16.62 | 18.56 | 4.32 | 25.52 | 4.61 |
| Enterprise Value (Cr.) | 37.27 | 55.57 | 46.62 | 54.46 | 43.64 |
| EV / Net Operating Revenue (X) | 0.49 | 0.93 | 1.04 | 1.64 | 1.29 |
| EV / EBITDA (X) | 11.81 | 14.76 | 22.70 | 9.78 | 20.85 |
| MarketCap / Net Operating Revenue (X) | 0.52 | 0.94 | 1.04 | 1.69 | 1.37 |
| Price / BV (X) | 0.37 | 0.58 | 0.57 | 0.73 | 0.60 |
| Price / Net Operating Revenue (X) | 0.52 | 0.94 | 1.04 | 1.69 | 1.37 |
| EarningsYield | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Deccan Health Care Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 5. It has decreased from 0.80 (Mar 24) to 0.54, marking a decrease of 0.26.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 5. It has decreased from 0.80 (Mar 24) to 0.45, marking a decrease of 0.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 3. It has decreased from 1.45 (Mar 24) to 1.11, marking a decrease of 0.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.42. It has decreased from 47.56 (Mar 24) to 45.42, marking a decrease of 2.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.42. It has decreased from 47.56 (Mar 24) to 45.42, marking a decrease of 2.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 32.04. It has increased from 29.31 (Mar 24) to 32.04, marking an increase of 2.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 2. It has decreased from 1.85 (Mar 24) to 1.35, marking a decrease of 0.50.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.72. This value is within the healthy range. It has decreased from 1.13 (Mar 24) to 0.72, marking a decrease of 0.41.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.69. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 0.69, marking a decrease of 0.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 2. It has decreased from 0.73 (Mar 24) to 0.49, marking a decrease of 0.24.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 2. It has decreased from 0.73 (Mar 24) to 0.49, marking a decrease of 0.24.
- For PBDIT Margin (%), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 10. It has decreased from 6.30 (Mar 24) to 4.20, marking a decrease of 2.10.
- For PBIT Margin (%), as of Mar 25, the value is 2.27. This value is below the healthy minimum of 10. It has decreased from 3.84 (Mar 24) to 2.27, marking a decrease of 1.57.
- For PBT Margin (%), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 10. It has decreased from 3.70 (Mar 24) to 2.17, marking a decrease of 1.53.
- For Net Profit Margin (%), as of Mar 25, the value is 1.54. This value is below the healthy minimum of 5. It has decreased from 2.49 (Mar 24) to 1.54, marking a decrease of 0.95.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.54. This value is below the healthy minimum of 8. It has decreased from 2.49 (Mar 24) to 1.54, marking a decrease of 0.95.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 15. It has decreased from 1.54 (Mar 24) to 1.08, marking a decrease of 0.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 10. It has decreased from 2.28 (Mar 24) to 1.56, marking a decrease of 0.72.
- For Return On Assets (%), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 5. It has decreased from 1.38 (Mar 24) to 0.92, marking a decrease of 0.46.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has increased from 0.58 (Mar 24) to 0.64, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 6.77. This value exceeds the healthy maximum of 3. It has decreased from 11.76 (Mar 24) to 6.77, marking a decrease of 4.99.
- For Quick Ratio (X), as of Mar 25, the value is 4.05. This value exceeds the healthy maximum of 2. It has decreased from 5.67 (Mar 24) to 4.05, marking a decrease of 1.62.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 4. It has increased from 0.65 (Mar 24) to 1.70, marking an increase of 1.05.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 42.55. This value is within the healthy range. It has decreased from 44.30 (Mar 24) to 42.55, marking a decrease of 1.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.62. This value is within the healthy range. It has decreased from 18.56 (Mar 24) to 16.62, marking a decrease of 1.94.
- For Enterprise Value (Cr.), as of Mar 25, the value is 37.27. It has decreased from 55.57 (Mar 24) to 37.27, marking a decrease of 18.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 24) to 0.49, marking a decrease of 0.44.
- For EV / EBITDA (X), as of Mar 25, the value is 11.81. This value is within the healthy range. It has decreased from 14.76 (Mar 24) to 11.81, marking a decrease of 2.95.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.52, marking a decrease of 0.42.
- For Price / BV (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.37, marking a decrease of 0.21.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.52, marking a decrease of 0.42.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Health Care Ltd:
- Net Profit Margin: 1.54%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.56% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.08% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.5 (Industry average Stock P/E: 94.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.54%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | 6-3-347/17/5/A/Back Position, Hyderabad Telangana 500082 | investors@deccanhealthcare.co.in http://www.deccanhealthcare.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Minto Purshotam Gupta | Managing Director |
| Ms. Bhavika Sanghani | Director |
| Ms. Meenakshi Gupta | Director |
| Mr. Ravi Ramprasad | Director |
| Mr. Umanja Venkata Satya Siva Sriharikolla | Director |
| Ms. Samhitha Kandlakunta | Independent Director |
| Ms. Ruchi Khattar | Independent Director |
| Mr. Viraj Shaileshkumar Shah | Independent Director |
FAQ
What is the intrinsic value of Deccan Health Care Ltd?
Deccan Health Care Ltd's intrinsic value (as of 13 December 2025) is 12.07 which is 25.95% lower the current market price of 16.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 40.2 Cr. market cap, FY2025-2026 high/low of 32.9/13.0, reserves of ₹84.21 Cr, and liabilities of 136.19 Cr.
What is the Market Cap of Deccan Health Care Ltd?
The Market Cap of Deccan Health Care Ltd is 40.2 Cr..
What is the current Stock Price of Deccan Health Care Ltd as on 13 December 2025?
The current stock price of Deccan Health Care Ltd as on 13 December 2025 is 16.3.
What is the High / Low of Deccan Health Care Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deccan Health Care Ltd stocks is 32.9/13.0.
What is the Stock P/E of Deccan Health Care Ltd?
The Stock P/E of Deccan Health Care Ltd is 28.5.
What is the Book Value of Deccan Health Care Ltd?
The Book Value of Deccan Health Care Ltd is 44.0.
What is the Dividend Yield of Deccan Health Care Ltd?
The Dividend Yield of Deccan Health Care Ltd is 0.00 %.
What is the ROCE of Deccan Health Care Ltd?
The ROCE of Deccan Health Care Ltd is 1.69 %.
What is the ROE of Deccan Health Care Ltd?
The ROE of Deccan Health Care Ltd is 1.18 %.
What is the Face Value of Deccan Health Care Ltd?
The Face Value of Deccan Health Care Ltd is 10.0.